Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles

Research in Virology

Volumn 145, Issue C, 1994, Pages 215-220

  Bender, A ^a,b   Schafer V ^a,b   Steffan, A M ^c   Royer, C ^c   Kreuter, J ^a   Rubsamen Waigmann H ^b   von Briesen, H ^b  

^a GOETHE UNIVERSITY   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Drug targeting; HIV, Nanoparticle, Microsphere, Antiviral agent, Macrophage

Indexed keywords

ANTIVIRUS AGENT; MICROSPHERE; NANOPARTICLE; ZALCITABINE; ZIDOVUDINE;

CONFERENCE PAPER; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MACROPHAGE; MONONUCLEAR CELL; PHAGOCYTE; PRIORITY JOURNAL; TARGET CELL; TRANSMISSION ELECTRON MICROSCOPY; VIRUS INHIBITION;

ANTIVIRAL AGENTS; HIV INFECTIONS; HIV-1; HUMAN; IN VITRO; MACROPHAGES; MICROSCOPY, ELECTRON; MICROSPHERES; MONOCYTES; PHAGOCYTOSIS; SERUM ALBUMIN; SUPPORT, NON-U.S. GOV'T; VEHICLES; ZALCITABINE; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0028030429     PISSN: 09232516     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2516(07)80025-2     Document Type: Article

References (19)

1. Primary cultures of human blood-borne macrophages grown on hydrophobic Teflon membranes
2. Infection of monocytes/macrophages by HIV in vitro
3. Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani
4. 14C-metacrylate) nanoparticle radioactivity after injection in rats and mice
5. Evaluation of nanoparticles as drugdelivery systems I: preparation methods
6. Pathogenesis of human immunodeficiency virus infection
7. Nanoparticles: a new colloidal drug delivery system
8. Macrophages and the human immunodeficiency virus
9. Liposomal encapsulation of 3′-azido-3′-deoxythymidine (AZT) results in decreased bone marrow toxicity and enhanced activity against murine AIDS-induced immunosuppression
10. HIV protease inhibitors: their anti-HIV activity and potential role in treatment
11. Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems
12. Role of the mononuclear phagocyte system in the development of acquired immunodeficiency syndrome (AIDS)
13. Reversal of HIV-phenotype to fulminant replication on macrophages in perinatal transmission.
14. Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: a possibility for antiviral drug targeting
15. Influence of HIV-infection on the phagocytic activity of monocytes/macrophages and granulocytes
16. Localisation of colloidal particles (liposomes, hexylcyanoacrylate nanoparticles and albumin nanoparticles) by histology and autoradiography in mice
17. Magnetic microspheres: synthesis of a novel parenteral drug carrier